Roumell withdraws nomination of Hellerman, supports management's efforts
CHEVY CHASE, Md., May 21, 2014
CHEVY CHASE, Md., May 21, 2014 /PRNewswire/ --
May 20, 2014
Board of Directors
Transcept Pharmaceuticals, Inc.
1003 W. Cutting Blvd.
Pt. Richmond, CA 94804
Consistent with our status as a passive shareholder, Roumell Asset Management
withdraws the nomination of Gerald Hellerman to the Board. We believe the
Company is taking the proper steps to maximize value for shareholders and is
diligently and methodically reviewing several potential transactions.
Moreover, we applaud the company's recent decision to promptly distribute $25
million in cash to shareholders.
James C. Roumell
SOURCE Roumell Asset Management, LLC
Contact: Roumell Asset Management, LLC, +1-301-656-8500
Press spacebar to pause and continue. Press esc to stop.